TScan Therapeutics, Inc. (TCRX)

Last Closing Price: 1.55 (2025-06-13)

Free Cash Flow per Share (Quarterly)

Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)

TScan Therapeutics, Inc. (TCRX) had Free Cash Flow per Share of $-0.30 for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$2.17M
$-34.13M
--
$2.17M
$38.42M
$-36.25M
$2.12M
$-34.13M
$-34.13M
$-34.13M
$-34.13M
$-34.13M
$-34.13M
$-36.25M
$-35.57M
129.68M
129.68M
$-0.26
$-0.26
Balance Sheet Financials
$254.84M
$8.35M
$77.87M
$332.71M
$29.82M
$32.18M
$92.69M
$122.51M
$210.20M
$210.20M
$210.20M
56.59M
Cash Flow Statement Financials
$-37.59M
$13.53M
$-0.53M
$183.72M
$159.14M
$-24.58M
$3.41M
--
--
Fundamental Metrics & Ratios
8.55
--
--
0.13
0.15
100.00%
-1669.74%
-1669.74%
--
-1571.95%
-1571.95%
$-39.12M
--
--
--
0.01
--
--
--
-16.24%
-16.24%
-10.26%
-14.08%
$3.71
Free Cash Flow per Share
$-0.30
$-0.29